For: | Kotlyarov S. Immune and metabolic cross-links in the pathogenesis of comorbid non-alcoholic fatty liver disease. World J Gastroenterol 2023; 29(4): 597-615 [PMID: 36742172 DOI: 10.3748/wjg.v29.i4.597] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v29/i4/597.htm |
Number | Citing Articles |
1 |
Nouhoum Bouare, Jean Delwaide. Interleukin-mediated therapies in liver diseases and comorbidity effects. World Journal of Hepatology 2024; 16(7): 980-989 doi: 10.4254/wjh.v16.i7.980
|
2 |
Hassam Ali, Muhammad Shahzil, Vishali Moond, Maria Shahzad, Abhay Thandavaram, Alina Sehar, Haniya Waseem, Taha Siddiqui, Dushyant Singh Dahiya, Pratik Patel, Hans Tillmann. Non-Pharmacological Approach to Diet and Exercise in Metabolic-Associated Fatty Liver Disease: Bridging the Gap between Research and Clinical Practice. Journal of Personalized Medicine 2024; 14(1): 61 doi: 10.3390/jpm14010061
|
3 |
Chang Yang, Kai Liu, Yanmin Deng, Qianhui Wang, Shiqian Cao, Qunlan Zhou. Multi-Omics Analysis Provides New Insights into the Interplay Between Gut Microbiota, Fatty Acid Metabolism, and Immune Response in Cultured and Wild Coilia nasus from the Yangtze River Area in China. Microorganisms 2025; 13(7): 1711 doi: 10.3390/microorganisms13071711
|
4 |
Kexing Xu, Qinmeng Zhang, Danji Zhu, Zhiwei Jiang. Hydrogels in Gene Delivery Techniques for Regenerative Medicine and Tissue Engineering. Macromolecular Bioscience 2024; 24(6) doi: 10.1002/mabi.202300577
|